Literature DB >> 8125834

The entry of meropenem into human macrophages and its immunomodulating activity.

A M Cuffini1, V Tullio, A Allocco, F Giachino, S Fazari, N A Carlone.   

Abstract

The uptake of meropenem by human macrophages and its consequences upon subsequent phagocytosis and killing of intracellular staphylococci has been studied. The cellular to extracellular concentration ratios (C/E) of meropenem were always high (range 3-12) at extracellular concentrations ranging from 0.125 to 1 mg/L. The uptake was not energy-dependent, being similar when viable and formalin-killed cells were used and was influenced neither by environmental temperature nor by the addition of a metabolic inhibitor. Meropenem at half the MIC caused a significant enhancement of phagocytosis and a reduction in the survival of intracellular Staphylococcus aureus. Pre-exposure of either staphylococci or macrophages to sub-MIC concentrations of meropenem led to an increase in uptake of bacteria and intracellular bactericidal activity by macrophages.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8125834     DOI: 10.1093/jac/32.5.695

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  7 in total

1.  Meropenem-clavulanic acid shows activity against Mycobacterium tuberculosis in vivo.

Authors:  Kathleen England; Helena I M Boshoff; Kriti Arora; Danielle Weiner; Emmanuel Dayao; Daniel Schimel; Laura E Via; Clifton E Barry
Journal:  Antimicrob Agents Chemother       Date:  2012-03-26       Impact factor: 5.191

2.  Use of Carbapenems against clinical, nontyphoid Salmonella isolates: results from in vitro and in vivo animal studies.

Authors:  Hung-Jen Tang; Chi-Chung Chen; Chun-Cheng Zhang; Kuo Chen Cheng; Shyh-Ren Chiang; Yu-Hsin Chiu; Yee Huang Ku; Wen-Chien Ko; Yin-Ching Chuang
Journal:  Antimicrob Agents Chemother       Date:  2012-04-02       Impact factor: 5.191

3.  Efficacy of High-Dose Meropenem (Six Grams per Day) in Treatment of Experimental Murine Pneumonia Induced by Meropenem-Resistant Pseudomonas aeruginosa.

Authors:  Kazuhiro Oshima; Shigeki Nakamura; Naoki Iwanaga; Koji Takemoto; Taiga Miyazaki; Kastunori Yanagihara; Yoshitsugu Miyazaki; Hiroshi Mukae; Shigeru Kohno; Koichi Izumikawa
Journal:  Antimicrob Agents Chemother       Date:  2016-12-27       Impact factor: 5.191

4.  Uptake of cefepime by phagocytosing polymorphonuclear neutrophils and subsequent intracellular killing.

Authors:  H Pruul; P J McDonald
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

Review 5.  Meropenem. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy.

Authors:  L R Wiseman; A J Wagstaff; R N Brogden; H M Bryson
Journal:  Drugs       Date:  1995-07       Impact factor: 9.546

6.  Entry of sanfetrinem into human polymorphonuclear granulocytes and its cell-associated activity against intracellular, penicillin-resistant Streptococcus pneumoniae.

Authors:  A M Cuffini; V Tullio; A Bonino; A Allocco; A I Palarchio; N A Carlone
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

7.  Escherichia coli-associated granulomatous colitis in dogs treated according to antimicrobial susceptibility profiling.

Authors:  Alison C Manchester; Belgin Dogan; Yongli Guo; Kenneth W Simpson
Journal:  J Vet Intern Med       Date:  2020-12-15       Impact factor: 3.175

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.